Jonathan Curio Profile
Jonathan Curio

@CurioJonathan

Followers
967
Following
2K
Media
228
Statuses
698

MD. Fascinated by Interventional Cardiology | Heart Center University Cologne @UKKoeln | Editorial Board @PCRonline | Visual Media Editor @JACCJournals #JACCCR

Cologne, Germany
Joined January 2018
Don't wanna be here? Send us removal request.
@CurioJonathan
Jonathan Curio
6 years
@JACCJournals
JACC Journals
6 years
Future percutaneous approaches might address the large unmet clinical need of severe #vhdTR. Learn more in #JACC. https://t.co/0vtzwwZOHC
0
6
15
@EuroInterventio
EuroIntervention
13 days
#EIJonAir - Analysis of the NOTION-2 trial
0
5
16
@GilbertTangMD
Dr. Gilbert Tang
29 days
Mild PVL after #TAVR is NO LONGER acceptable, especially in low/intermediate risk and younger patients. In #JACCINT @JACCJournals the OCEAN-TAVI registry showed long-term higher mortality and TAV failure even with mild PVL. Minimizing PVL when safe should be routine now. 2
2
41
136
@CurioJonathan
Jonathan Curio
1 month
⭐New insights from TRIPLACE featured at #PCRLV: PVL after #TTVR by @AndreaScotti21 et al. 🎯 6.1% w/ >/= mod PVL (predicted by large RA, malpositioning, type IV morphology) 🎯>/= mod translated into ⬆️1y mort ➡️May have key implications for procedural optimization+device design
1
5
7
@CurioJonathan
Jonathan Curio
1 month
Latest Science for #treatTR featured at #PCRLV: RV remodelling after Lux- Valve #TTVR by Kobari et al. 🎯Sufficient+sustained TR reduction at 1y 🎯Translated into pos RV remodelling, espec in pt w/ TAPSE/sPAP > 0.3 ➡️Prognostic implications of RV remodelling need to be studied
2
3
9
@CurioJonathan
Jonathan Curio
1 month
🚀Additional insights from TRISCEND + TRISCEND II #treatTR: Multivalve disease in #TTVR by @JennifervStein et al. ⭐Find the key takes of the study in the @PCRonline #PCRLV e-Poster⤵️
1
1
1
@CurioJonathan
Jonathan Curio
1 month
🚀New insights into TRISCEND/TRISCEND II #treatTR: #TTVR in pt w/ CIED lead by @JennifervStein et al. 🎯130 of 337 patients w/CIED lead in place; showed similar proc safety 🎯7.7% w/lead related event 🎯Events could be managed well by lead repositioning or leadless pacer implant
1
2
8
@CurioJonathan
Jonathan Curio
1 month
🚀Latest #treatTR Science at #PCRLV: Tri-Repair Score predicts 1y mort/HF Hosp/TR⤵️by Weber et al. 🎯8 items (RV funct, TV dimension+config.,labs) 🎯AUC mort 0.64, HF hosp >0.66, TR⤵️>0.67 ➡️Compared to establ. TRI-SCORE bit worse predictive 4 mort, but better 4 HF hosp & TR⤵️
1
1
5
@CurioJonathan
Jonathan Curio
1 month
Latest Science for #treatTR featured at #PCRLV @PCRonline: RV remodelling after EVOQUE #TTVR by Hungerford et al. 🎯Some immediate decline in RV function 🎯No immediate change in RV volumes, but volume release at f/u ➡️RV-FW strain may inform on those w/ RV funct recovery?
1
1
3
@TagliariPaula
Ana Paula Tagliari
1 month
0
12
21
@CurioJonathan
Jonathan Curio
1 month
Evidence card on novel device for targeted CIED lead placement to mitigate TR⬆️ @BenekiEirini @MiChen__ @juliendreyfus1 @jcecharte @DrGarot @cvnurselin @drtsakamoto @a_sorropago @TagliariPaula @m_taramasso @dr_tyxiong
0
0
0
@CurioJonathan
Jonathan Curio
1 month
🚀#PCRLV Tricuspid Hotline Session: Novel device for targeted commissural placement of pacing leads mitigating TR by Vini Bapat et al. 🎯Find the key takes of the study in the @PCRonline Evidence Card ⤵️ @PCRonline @PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD
1
7
12
@CurioJonathan
Jonathan Curio
1 month
0
0
0
@CurioJonathan
Jonathan Curio
1 month
🚀#PCRLV Tricuspid Hotline Session: Predictors of HF hospitalisation post TTVR - TRISCEND + TRISCEND II analysis by Sannino et al. 🎯Find the key takes of the study in the @PCRonline Evidence Card ⤵️ @PamelaGatto @alcantaramonica @dr_chrisallen @O_Azizy_MD @BenekiEirini
1
3
9
@CurioJonathan
Jonathan Curio
1 month
0
0
0